The present invention relates to a new compound, 4 - (1-phenyl-1h - [1,2,3] triazol-4-yl) - phenyllafamate derivatives and 4 - (1-phenyl-1h - [1,2,3] triazol-4-yl) - phenol derivatives.The subject matter of the present invention is for medical applications of 4 - (1-phenyl-1h - [1,2,3] triazol-4-yl) - phenyllafate derivatives and 4 - (1-phenyl-1h - [1,2,3] triazole-4-yl) - phenol derivatives.The subject matter of the present invention is the use of a novel compound as a drug having the properties of a steroid sulfatase inhibitor and / or estrogen receptor modulator.The present invention relates to medical applications of novel compounds used as antimicrobial agents and / or estrogen receptor modulators.Specifically, 4 - (1-phenyl-1h - [1,2,3] triazol-4-yl) - phenylsulfamate derivatives are used as medications in the treatment of cancer.The present invention also relates to the preparation process of these new compounds, and 4 - (1-phenyl-1h - [1,2,3] triazol-4-yl) - phenol derivatives are intermediate products obtained by sulfamate derivatives.No selection
展开▼